Oscar Health Increases CEO Bertolini’s Pay to $1.3 Million and Grants $45 Million in Equity Awards

Reuters2025-12-30
<a href="https://laohu8.com/S/OSCR">Oscar</a> Health Increases CEO Bertolini’s Pay to $1.3 Million and Grants $45 Million in Equity Awards

Oscar Health Inc. has announced an amended and restated employment agreement with CEO Mark T. Bertolini, effective December 22, 2025. Under the new agreement, Bertolini’s annual base salary is set at $1,300,000, and, starting in 2026, his target annual bonus will increase to 150% of his base salary. In the first quarter of 2026, Bertolini will receive restricted stock unit (RSU) awards valued at $45 million, split evenly between time-based and performance-based awards. He is not expected to receive additional long-term incentive or equity-based awards before 2029. If his employment is terminated without cause or if he resigns for good reason, Bertolini will be eligible for a cash severance of 1.5 times his salary and 18 months of subsidized healthcare coverage. The agreement is set to run through April 1, 2029, with automatic one-year renewals unless either party opts out.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oscar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-335294), on December 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment